Literature DB >> 18060842

HIV-1 T-cell vaccines: evaluating the next step.

Giuseppe Pantaleo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060842     DOI: 10.1016/S1473-3099(07)70266-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  15 in total

1.  Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.

Authors:  Sunil Kannanganat; Pragati Nigam; Vijayakumar Velu; Patricia L Earl; Lilin Lai; Lakshmi Chennareddi; Benton Lawson; Robert L Wilson; David C Montefiori; Pamela A Kozlowski; Bernard Moss; Harriet L Robinson; Rama Rao Amara
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

2.  The STEP study provides a hint that vaccine induction of the right CD8+ T cell responses can facilitate immune control of HIV.

Authors:  Marcus Altfeld; Philip J Goulder
Journal:  J Infect Dis       Date:  2011-03-15       Impact factor: 5.226

Review 3.  Polyvalent AIDS vaccines.

Authors:  Shan Lu; Jill M Grimes Serrano; Shixia Wang
Journal:  Curr HIV Res       Date:  2010-12       Impact factor: 1.581

4.  AIDSVAX immunization induces HIV-specific CD8+ T-cell responses in high-risk, HIV-negative volunteers who subsequently acquire HIV infection.

Authors:  Norman G Jones; Allan DeCamp; Peter Gilbert; Michael L Peterson; Marc Gurwith; Huyen Cao
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

5.  Myd88 is required for an antibody response to retroviral infection.

Authors:  Edward P Browne; Dan R Littman
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

6.  Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.

Authors:  Meritxell Genescà; Michael B McChesney; Christopher J Miller
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

Review 7.  Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).

Authors:  Michael Vaine; Shan Lu; Shixia Wang
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

8.  With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.

Authors:  Meritxell Genescà; Pamela J Skinner; Jung Joo Hong; Jun Li; Ding Lu; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

9.  Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression.

Authors:  Melissa-Rose Abrahams; Florette K Treurnicht; Nobubelo K Ngandu; Sarah A Goodier; Jinny C Marais; Helba Bredell; Ruwayhida Thebus; Debra de Assis Rosa; Koleka Mlisana; Cathal Seoighe; Salim Abdool Karim; Clive M Gray; Carolyn Williamson
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

10.  HIV vaccination: turning the spotlight on effector memory T cells as mucosal gatekeepers.

Authors:  Hilde Cheroutre
Journal:  F1000 Biol Rep       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.